Details:

Alternative Title:
Yale J Biol Med
Personal Author:
Iskander, John K. ; Haber, Penina ; Herrera, Guillermo
Iskander, John K. ; Haber, Penina ; Herrera, Guillermo Less -
Description:
In the event that a vaccine is available during an influenza pandemic, vaccine safety monitoring will occur as part of comprehensive public health surveillance of the vaccination campaign. Though inactivated influenza vaccines have been widely used in the United States and much is known about their safety profile, attention will need to be paid to both common self-limited adverse reactions and rarer, more serious events that may or may not be causally related to vaccination. The primary surveillance systems used to generate and test hypotheses about vaccine safety concerns are the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD), respectively. Examples of recent use of these systems to investigate influenza vaccine safety and enhancements planned for use during a pandemic are presented. Ethical issues that will need to be addressed as part of an overall vaccine safety response include risk communication and injury compensation. Advance planning and the use of available technologic solutions are needed to respond to the scientific and logistic challenges involved in safely implementing mass vaccination during a pandemic.
Subjects:
[+]
Adverse Drug Reaction Reporting Systems Disaster Planning Disease Notification Disease Outbreaks Drug-Related Side Effects And Adverse Reactions Humans Influenza, Human Influenza Vaccines Mandatory Reporting Population Surveillance
Source:
Yale J Biol Med. 78(5):265-275.
Document Type:
Journal Article
Place as Subject:
United States
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:472567461d56c77d7a0c8da2eac3c12ae856eff0cd088705d512c9b5948cd110
Download URL:
https://stacks.cdc.gov/view/cdc/3598/cdc_3598_DS1.pdf
File Type:

Supporting Files

• 	17132333.nxml	txt
  	license.txt	txt

More +